Kazia Therapeutics (KZIA) Current Deferred Revenue (2017 - 2018)

Generated on {Timestamp} © BusinessQuant.com

Generated on {Timestamp} Powered by

Kazia Therapeutics (KZIA) has disclosed Current Deferred Revenue for 2 consecutive years, with $104471.1 as the latest value for Q2 2018.

• For the quarter ending Q2 2018, Current Deferred Revenue rose 239.2% year-over-year to $104471.1, compared with a TTM value of $104471.1 through Jun 2018, up 239.2%, and an annual FY2018 reading of $104471.1, up 237.91% over the prior year.
• Current Deferred Revenue was $104471.1 for Q2 2018 at Kazia Therapeutics, up from $30799.6 in the prior quarter.
• Across five years, Current Deferred Revenue topped out at $104471.1 in Q2 2018 and bottomed at $30799.6 in Q2 2017.

Peer Comparison